Jain Global’s Tenaya Therapeutics TNYA Stock Holding History

Jain Global’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-79,882	Closed	-$48.8K	–	1491
2025 Q2	$48.8K	Buy	+79,882	New	+$40.7K	﹤0.01%	1096

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Jain Global's TNYA Position: Q3 2025 in Review

Jain Global sold out of Tenaya Therapeutics (TNYA) in Q3 2025, closing a stake of 79,882 shares — an estimated $48.8K sold.

Jain Global first reported a position in TNYA in Q2 2025 and held it in 1 quarter. The position peaked at $48.8K in Q2 2025. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

Jain Global reported no remaining Tenaya Therapeutics position as of Q3 2025 after selling out during the quarter.
Jain Global sold 79,882 Tenaya Therapeutics shares in Q3 2025, an estimated $48.8K.
Jain Global first reported a position in Tenaya Therapeutics in Q2 2025 and held it in 1 quarter.
Jain Global's Tenaya Therapeutics position peaked at $48.8K in Q2 2025.
91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.